Concepts (159)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Antineoplastic Agents, Phytogenic | 6 | 2020 | 626 | 1.540 |
Why?
|
Paclitaxel | 8 | 2020 | 1736 | 1.470 |
Why?
|
Drug Delivery Systems | 8 | 2024 | 2221 | 1.430 |
Why?
|
Nanoparticles | 8 | 2023 | 1943 | 1.140 |
Why?
|
Aerosols | 5 | 2020 | 632 | 1.040 |
Why?
|
Nanotechnology | 3 | 2018 | 709 | 0.830 |
Why?
|
Melanoma, Experimental | 2 | 2014 | 562 | 0.720 |
Why?
|
Pulmonary Surfactants | 2 | 2018 | 161 | 0.690 |
Why?
|
Central Nervous System Diseases | 1 | 2024 | 521 | 0.680 |
Why?
|
Biomimetic Materials | 3 | 2018 | 173 | 0.670 |
Why?
|
Diphtheria Toxin | 1 | 2020 | 252 | 0.670 |
Why?
|
Nanocapsules | 3 | 2014 | 92 | 0.590 |
Why?
|
Endosomes | 1 | 2020 | 519 | 0.580 |
Why?
|
Urinary Bladder | 1 | 2024 | 1166 | 0.580 |
Why?
|
Phosphatidylserines | 3 | 2020 | 188 | 0.490 |
Why?
|
Nanospheres | 1 | 2014 | 21 | 0.490 |
Why?
|
Delayed-Action Preparations | 3 | 2020 | 961 | 0.470 |
Why?
|
Osteoarthritis | 1 | 2022 | 1055 | 0.460 |
Why?
|
Transport Vesicles | 1 | 2013 | 81 | 0.420 |
Why?
|
Drug Carriers | 5 | 2021 | 709 | 0.400 |
Why?
|
Administration, Inhalation | 4 | 2018 | 1156 | 0.400 |
Why?
|
Chitosan | 1 | 2013 | 131 | 0.400 |
Why?
|
Lipids | 2 | 2013 | 3336 | 0.390 |
Why?
|
Lung Diseases | 1 | 2018 | 1915 | 0.290 |
Why?
|
Colonic Neoplasms | 2 | 2020 | 2526 | 0.280 |
Why?
|
Lung Neoplasms | 4 | 2020 | 13262 | 0.270 |
Why?
|
Nanomedicine | 3 | 2021 | 288 | 0.260 |
Why?
|
Pharmaceutical Preparations | 2 | 2024 | 1091 | 0.240 |
Why?
|
Administration, Intravesical | 1 | 2024 | 92 | 0.230 |
Why?
|
Phosphatidylethanolamines | 2 | 2014 | 129 | 0.230 |
Why?
|
Rats, Wistar | 4 | 2020 | 1850 | 0.220 |
Why?
|
Biocompatible Materials | 3 | 2024 | 1689 | 0.220 |
Why?
|
Arthritis, Rheumatoid | 1 | 2018 | 3763 | 0.210 |
Why?
|
Cell Line, Tumor | 8 | 2016 | 16939 | 0.200 |
Why?
|
RNA, Small Interfering | 2 | 2021 | 3442 | 0.190 |
Why?
|
Chondrocytes | 2 | 2018 | 791 | 0.180 |
Why?
|
Injections, Intra-Articular | 1 | 2022 | 279 | 0.180 |
Why?
|
Drug Synergism | 3 | 2014 | 1754 | 0.180 |
Why?
|
Sesquiterpenes | 1 | 2021 | 176 | 0.170 |
Why?
|
Gene Transfer Techniques | 1 | 2024 | 1204 | 0.160 |
Why?
|
Ultrasonic Therapy | 1 | 2021 | 215 | 0.160 |
Why?
|
Apoptosis | 2 | 2014 | 9501 | 0.160 |
Why?
|
Reactive Oxygen Species | 2 | 2024 | 2138 | 0.160 |
Why?
|
Pulmonary Surfactant-Associated Proteins | 1 | 2018 | 17 | 0.160 |
Why?
|
Inflammation | 1 | 2018 | 10756 | 0.150 |
Why?
|
Hydrogels | 3 | 2019 | 723 | 0.150 |
Why?
|
Triamcinolone Acetonide | 1 | 2018 | 100 | 0.150 |
Why?
|
Animals | 15 | 2024 | 167963 | 0.150 |
Why?
|
Blood-Brain Barrier | 2 | 2021 | 1019 | 0.130 |
Why?
|
Particle Size | 2 | 2021 | 1644 | 0.130 |
Why?
|
Synovial Fluid | 1 | 2018 | 395 | 0.130 |
Why?
|
Tacrolimus | 1 | 2019 | 733 | 0.120 |
Why?
|
1,2-Dipalmitoylphosphatidylcholine | 1 | 2014 | 41 | 0.120 |
Why?
|
Skin Neoplasms | 1 | 2014 | 5799 | 0.120 |
Why?
|
Mice, Nude | 3 | 2020 | 3607 | 0.120 |
Why?
|
Mice | 8 | 2021 | 81208 | 0.120 |
Why?
|
Hyaline Cartilage | 1 | 2014 | 9 | 0.120 |
Why?
|
Protein Transport | 1 | 2020 | 1964 | 0.120 |
Why?
|
Gastrointestinal Agents | 1 | 2019 | 509 | 0.120 |
Why?
|
Prodrugs | 1 | 2016 | 259 | 0.110 |
Why?
|
Digestive System Surgical Procedures | 1 | 2019 | 575 | 0.110 |
Why?
|
Lung | 4 | 2020 | 9994 | 0.110 |
Why?
|
Adenocarcinoma | 1 | 2011 | 6315 | 0.110 |
Why?
|
Chemistry, Pharmaceutical | 1 | 2014 | 276 | 0.110 |
Why?
|
Injections, Intravenous | 1 | 2014 | 1385 | 0.100 |
Why?
|
Phosphorylcholine | 1 | 2012 | 153 | 0.100 |
Why?
|
Hemolysis | 1 | 2014 | 423 | 0.100 |
Why?
|
Rats | 4 | 2020 | 23711 | 0.090 |
Why?
|
Mice, Inbred C57BL | 4 | 2018 | 22023 | 0.090 |
Why?
|
Purines | 1 | 2014 | 605 | 0.090 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2016 | 498 | 0.090 |
Why?
|
Vasodilation | 1 | 2014 | 962 | 0.090 |
Why?
|
Administration, Oral | 2 | 2020 | 4035 | 0.090 |
Why?
|
Cell Culture Techniques | 1 | 2017 | 1664 | 0.090 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2014 | 2502 | 0.090 |
Why?
|
Extracellular Matrix | 1 | 2017 | 1726 | 0.090 |
Why?
|
Surface Properties | 1 | 2013 | 1161 | 0.090 |
Why?
|
Immunosuppressive Agents | 2 | 2019 | 4166 | 0.080 |
Why?
|
Drug Design | 1 | 2014 | 1061 | 0.080 |
Why?
|
Humans | 20 | 2024 | 760621 | 0.080 |
Why?
|
Antineoplastic Agents | 3 | 2018 | 13630 | 0.080 |
Why?
|
Monocytes | 1 | 2018 | 2575 | 0.080 |
Why?
|
Intestines | 1 | 2017 | 1907 | 0.080 |
Why?
|
Imidazoles | 1 | 2014 | 1180 | 0.080 |
Why?
|
Anti-Inflammatory Agents | 1 | 2018 | 1796 | 0.080 |
Why?
|
Immunotherapy | 1 | 2024 | 4642 | 0.080 |
Why?
|
Nuclear Proteins | 1 | 2023 | 5791 | 0.080 |
Why?
|
Cell Survival | 2 | 2014 | 5797 | 0.070 |
Why?
|
Nanostructures | 1 | 2012 | 547 | 0.070 |
Why?
|
Tissue Scaffolds | 1 | 2014 | 928 | 0.070 |
Why?
|
HeLa Cells | 1 | 2013 | 3105 | 0.070 |
Why?
|
Molecular Targeted Therapy | 1 | 2018 | 2803 | 0.070 |
Why?
|
Regeneration | 1 | 2014 | 1506 | 0.060 |
Why?
|
Stem Cells | 1 | 2017 | 3523 | 0.060 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2019 | 2421 | 0.060 |
Why?
|
Molecular Structure | 2 | 2021 | 1895 | 0.060 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2020 | 5253 | 0.060 |
Why?
|
Neoplasms | 3 | 2024 | 22072 | 0.050 |
Why?
|
Pyridines | 1 | 2014 | 2879 | 0.050 |
Why?
|
Protein Binding | 1 | 2014 | 9335 | 0.050 |
Why?
|
Inhibitory Concentration 50 | 1 | 2020 | 465 | 0.040 |
Why?
|
HCT116 Cells | 1 | 2020 | 402 | 0.040 |
Why?
|
Drug Resistance, Multiple | 1 | 2020 | 254 | 0.040 |
Why?
|
Forelimb | 1 | 2019 | 115 | 0.040 |
Why?
|
Drug Implants | 1 | 2019 | 230 | 0.040 |
Why?
|
Collagen Type IV | 1 | 2017 | 127 | 0.040 |
Why?
|
Glioblastoma | 1 | 2012 | 3484 | 0.040 |
Why?
|
Drug Compounding | 1 | 2018 | 246 | 0.030 |
Why?
|
Swine, Miniature | 1 | 2019 | 959 | 0.030 |
Why?
|
Laminin | 1 | 2017 | 405 | 0.030 |
Why?
|
Cell Proliferation | 3 | 2017 | 10446 | 0.030 |
Why?
|
Coated Materials, Biocompatible | 1 | 2017 | 318 | 0.030 |
Why?
|
Polyglycolic Acid | 1 | 2016 | 405 | 0.030 |
Why?
|
Adhesiveness | 1 | 2014 | 52 | 0.030 |
Why?
|
Proteoglycans | 1 | 2017 | 801 | 0.030 |
Why?
|
Hexuronic Acids | 1 | 2014 | 145 | 0.030 |
Why?
|
Glucuronic Acid | 1 | 2014 | 150 | 0.030 |
Why?
|
Brain | 1 | 2021 | 26951 | 0.030 |
Why?
|
Prostatic Neoplasms | 1 | 2016 | 11345 | 0.030 |
Why?
|
Alginates | 1 | 2014 | 248 | 0.030 |
Why?
|
Tissue Adhesives | 1 | 2014 | 173 | 0.030 |
Why?
|
Gelatin | 1 | 2014 | 221 | 0.030 |
Why?
|
Models, Animal | 1 | 2019 | 2117 | 0.030 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2014 | 717 | 0.020 |
Why?
|
Green Fluorescent Proteins | 1 | 2017 | 2057 | 0.020 |
Why?
|
Female | 4 | 2014 | 391270 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2020 | 3584 | 0.020 |
Why?
|
Drug Combinations | 1 | 2017 | 2025 | 0.020 |
Why?
|
Equipment Failure Analysis | 1 | 2014 | 848 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2012 | 11712 | 0.020 |
Why?
|
Injections | 1 | 2014 | 830 | 0.020 |
Why?
|
Brain Neoplasms | 1 | 2012 | 8986 | 0.020 |
Why?
|
Cross-Linking Reagents | 1 | 2014 | 685 | 0.020 |
Why?
|
Drug Approval | 1 | 2018 | 816 | 0.020 |
Why?
|
Lactic Acid | 1 | 2016 | 1134 | 0.020 |
Why?
|
Materials Testing | 1 | 2014 | 862 | 0.020 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2017 | 1245 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2016 | 18957 | 0.020 |
Why?
|
Collagen | 1 | 2017 | 2636 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2014 | 3084 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2021 | 8552 | 0.020 |
Why?
|
Swine | 1 | 2019 | 5899 | 0.020 |
Why?
|
Graft Survival | 1 | 2019 | 3794 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2014 | 2222 | 0.020 |
Why?
|
Prostate | 1 | 2016 | 1793 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2014 | 3094 | 0.020 |
Why?
|
Male | 4 | 2020 | 359744 | 0.020 |
Why?
|
Pyrazoles | 1 | 2017 | 1999 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2014 | 2135 | 0.020 |
Why?
|
Prostate-Specific Antigen | 1 | 2016 | 2529 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2013 | 65017 | 0.020 |
Why?
|
Graft Rejection | 1 | 2019 | 4426 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2017 | 3663 | 0.020 |
Why?
|
Pyrimidines | 1 | 2017 | 3016 | 0.020 |
Why?
|
Mesenchymal Stem Cells | 1 | 2016 | 1634 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 2019 | 3527 | 0.020 |
Why?
|
Tissue Engineering | 1 | 2014 | 1870 | 0.010 |
Why?
|
Transcription Factors | 1 | 2023 | 12103 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2014 | 10827 | 0.010 |
Why?
|
Concepts
(159)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(19)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_